Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Keratosis, Actinic 4Nasopharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Locally Advanced Rectal Cancer 1Keratosis 1Hyperthermia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Appendiceal Neoplasms 1Anus Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Colorectal Cancer 1

Interventions

irinotecan sucrosofate 1Oxaliplatin 1Fluorouracil 1Diathermy 1Combined Modality Therapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Locally Advanced Rectal Cancer × Fluorouracil × Clear all
NCT06894797 2025-03-25

Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.

Peking University Cancer Hospital & Institute

Phase NA Recruiting
68 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡